# OXYGEN DEVELOPMENT, L.L.C. - Inspection Records

Source: https://www.keypedia.com/companies/oxygen-development-llc/024c27c1-6cfa-4c7b-9daf-9005cbf515b7

> Inspection records and compliance data for OXYGEN DEVELOPMENT, L.L.C. in Palm Springs, Florida. Access full analysis and detailed observations.

---

## Details

- Name: OXYGEN DEVELOPMENT, L.L.C.
- FEI Number: 3009461317
- City: Palm Springs
- State: Florida
- Country Name: United States
- Address Line 1: 1525 S Congress Ave
- Zip Code: 33406

## Related Documents

- [FDA Inspection 1295654 - OXYGEN DEVELOPMENT, L.L.C. - 2026-05-19](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/b6de52e9-9392-4984-a3ef-b645e07c565e) — classification: No Action Indicated (NAI), source: FDA, date: May 19, 2026
- [483 - OXYGEN DEVELOPMENT, L.L.C. - 2025-09-11](https://www.keypedia.com/records/483/oxygen-development-llc/b36d2d36-735e-40c3-a882-a4a6d8fdb1ce) — source: FDA, date: September 11, 2025
- [FDA Inspection 1250745 - OXYGEN DEVELOPMENT, L.L.C. - 2025-09-11](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/951e75e0-9474-4220-8341-ba8cd5ae30a1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 11, 2025
- [EIR - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-19](https://www.keypedia.com/records/eir/oxygen-development-llc/01acffc0-62e1-48a8-bffe-1151ef309b5b) — source: FDA, date: January 19, 2018
- [FDA Inspection 1042460 - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-19](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/04fc63c5-43ea-4896-abfe-236d6dad1098) — classification: No Action Indicated (NAI), source: FDA, date: January 19, 2018
- [EIR - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-17](https://www.keypedia.com/records/eir/oxygen-development-llc/52199a5f-bd75-44ae-95ec-33420199da2c) — source: FDA, date: January 17, 2018
- [483 - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-17](https://www.keypedia.com/records/483/oxygen-development-llc/8a8320a3-2cff-4b58-955c-fef5cb2a96d1) — source: FDA, date: January 17, 2018
- [FDA Inspection 1039561 - OXYGEN DEVELOPMENT, L.L.C. - 2018-01-17](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/9deefb7a-9015-45ac-b4cf-eb9d000bd06d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 17, 2018
- [FDA Inspection 857278 - OXYGEN DEVELOPMENT, L.L.C. - 2013-11-22](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/83b1d754-fed3-4709-8a26-932a779f6a8b) — classification: No Action Indicated (NAI), source: FDA, date: November 22, 2013
- [FDA Inspection 857278 - OXYGEN DEVELOPMENT, L.L.C. - 2013-11-22](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/229a4661-b57a-4cd5-8d1c-bc1af2884b80) — classification: No Action Indicated (NAI), source: FDA, date: November 22, 2013
- [FDA Inspection 857278 - OXYGEN DEVELOPMENT, L.L.C. - 2013-11-22](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/0cf9746a-9561-4d22-970a-0f4837f177ff) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 22, 2013
- [FDA Inspection 824681 - OXYGEN DEVELOPMENT, L.L.C. - 2013-03-29](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/71aada83-67bb-4e02-ae37-670289f578ea) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2013
- [FDA Inspection 824681 - OXYGEN DEVELOPMENT, L.L.C. - 2013-03-29](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/362052f5-8eba-41f1-b5f2-8a6fcde28af7) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2013
- [FDA Inspection 775347 - OXYGEN DEVELOPMENT, L.L.C. - 2012-05-11](https://www.keypedia.com/records/fda_inspections/oxygen-development-llc/f1c2a2c7-8908-4fa2-bee4-d757bc3ea54d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 11, 2012

## Related Companies

- [Hospira Australia Pty Ltd.](https://www.keypedia.com/companies/hospira-australia-pty-ltd/43f04346-c63c-4c33-92ed-a42abafdd533)
- [Lannett Company Inc.](https://www.keypedia.com/companies/lannett-company-inc/d4d7f04f-0ec5-4f5a-868b-d48963202cc8)
- [Quality Packaging Specialists International, LLC](https://www.keypedia.com/companies/quality-packaging-specialists-international-llc/74a9861b-efac-463e-b6f9-bd1e22db674a)
- [Frontage Laboratories, Inc.](https://www.keypedia.com/companies/frontage-laboratories-inc/1705f97d-14a3-4e46-b8a5-220bf2c4799f)
- [BOEHRINGER INGELHEIM PROMECO S.A. de C.V.](https://www.keypedia.com/companies/boehringer-ingelheim-promeco-sa-de-cv/d1f077c2-d2d3-4a71-b897-7595adbb343b)
- [Virbac Corporation](https://www.keypedia.com/companies/virbac-corporation/50f11944-6101-41cc-826d-abc0520ba802)
- [Aphena Pharma Solutions-Maryland LLC](https://www.keypedia.com/companies/aphena-pharma-solutions-maryland-llc/97893fd6-3370-41f2-95ce-17928ab057e2)
- [Norwich Pharmaceuticals, Inc.](https://www.keypedia.com/companies/norwich-pharmaceuticals-inc/24e5093f-2fde-40ab-a0a9-518fb46c4bfd)
- [Alk-abello, Inc.](https://www.keypedia.com/companies/alk-abello-inc/88a052a0-f653-45ca-a45e-89003e4e8565)
- [Sharp Clinical Services, LLC](https://www.keypedia.com/companies/sharp-clinical-services-llc/d1817364-b3cb-41a2-818e-dea1083e5827)

## Related Officers

- [Jennifer L. Huntington](https://www.keypedia.com/people/jennifer-l-huntington/c04e1c86-c7ec-4613-b3f7-a1f9ba2b2f2c)
- [company_representative](https://www.keypedia.com/people/linda-fundo/12a96a3e-8493-44de-8feb-9b9a9139045f)
- [issuing_officer](https://www.keypedia.com/people/frances-m-rivera-rosario/23aa886e-b113-4366-97f2-5bd719d60a41)